Frontal acquired brain injury, substance abuse and their common psychological symptoms in the Iranian population

Brain Injury

Volumn 25, Issue 12, 2011, Pages 1249-1255

  Banihashemian, Kourosh ^a   Pour, Razieh Etesami ^a   Moazzen, Mansour ^b  

^a Iran Jahrom Azadegan Blv Payam e Nour University   (Iran)

^b PAYAME NOOR UNIVERSITY   (Iran)

Author keywords

Frontal brain injury; Substance abuse; Symptoms

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; APATHY; ARTICLE; BRAIN INJURY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; FRONTAL ACQUIRED BRAIN INJURY; FRONTAL SYSTEMS BEHAVIORAL SCALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; SUBSTANCE ABUSE;

EID: 80053640886     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2011.608208     Document Type: Article

References (24)

1. Verdejo-García A, Bechara A, Recknor E, Pérez-García M. Executive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioural, cognitive and emotional correlates of addiction. Journal of The International Neuropsychological Society 2006;12: 405-415. (Pubitemid 43970906)
2. Lange RT, Iverson GL, Franzen MD. Neuropsychological functioning following complicated vs. uncomplicated traumatic brain injury. Brain Injury 2009;23(2):83-91.
3. Kashluba S, Paniak C, Casey JE. Persistent symptoms associated with factors identified by the WHO Task Force on Mild Traumatic Brain Injury. Clinical Neuropsychologist 2008;22(2):195-208. (Pubitemid 351507786)
4. Lipton ML, Gulko E, Zimmerman ME, et al. Diffusiontensor imaging implicates prefrontal axonal injury in executive function impairment following very mild traumatic brain injury. Radiology 2009;252(3):816-824.
5. Garavan H, Stout JC. Neurocognitive insights into substance abuse. Trends in Cognitive Sciences 2005;9: 195-201. (Pubitemid 40543255)
6. Verdejo-García A, López-Torrecillas F, Orozco C, Pérez- García M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant and opioid abuse. Neuropsychology Review 2004;14(1):1-41. (Pubitemid 39023955)
7. Grace J, Malloy PF. Frontal Systems Behavior Scale (FrSBe): Professional Manual. Lutz, FL: Psychological Assessment Resources; 2001.
8. Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH. Cognitive and behavioural features discriminate between Alzheimer's and Parkinson's disease. Neuropsychiatry Neuropsychology and Behavioral Neurology 2002;15(2):79-87. (Pubitemid 34625859)
9. Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Multiple Sclerosis 2005;11:203-212. (Pubitemid 40403261)
10. Velligan DI, Ritch JL, Sui D, Dicocco M, Huntzinger CD. Frontal Systems Behavior Scale in schizophrenia: Relationships with psychiatric symptomatology, cognition and adaptative function. Psychiatry Research 2002;113(3): 227-236. (Pubitemid 36136045)
11. Spinella M. Relationship between drug use and prefrontal associated traits. Addiction Biology 2003;8: 67-74. (Pubitemid 36433982)
12. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. American Journal of Geriatric Psychiatry 2003;11(2): 214-221. (Pubitemid 36254195)
13. Spinella M, Yang B, Lester D. Prefrontal system dysfunction and credit card debt. International Journal of Neuroscience 2004;114(10):1323-1332. (Pubitemid 39243554)
14. Verdejo-García A, Rivas-Pérez C, López-Torrecillas F, Pérez-García M. Differential impact of severity of drug use on frontal behavioral symptoms. Addictive Behaviors 2006;31: 1373-1382. (Pubitemid 44093863)
15. Malloy P, Grace J. A review of rating scales for measuring behavior change due to frontal systems damage. Cognitive and Behavioral Neurology 2005;18:18-27. (Pubitemid 40381366)
16. Stout JC, Wyman MF, Johnson SA, Peavy GM, Salmon DP. Frontal behavioral syndromes and functional status in probable Alzheimer's disease. American Journal of Geriatric Psychiatry 2003;11(6):683-686. (Pubitemid 37392334)
17. Caracuel-Romero A, Pérez-García M, Salinas-Sánchez I, Asensio-Avilés MM, Sánchez-Castaño JM, Pérez-Ureña MB. Datos preliminares de la adaptación a un servicio de rehabilitación pú blico de un programa holístico de rehabilitación neuropsicoló gica para pacientes con daño cerebral adquirido. Rehabilitación (Madr) 2005;32(3): 95-102.
18. Verdejo-García A, Pérez-García M. Substance abusers' selfawareness of the neurobehavoiral consequences of addiction. Psychiatry Research 2008;158:172-180.
19. Stout JC, Rodawalt WC, Siemers ER. Risky decision making in Huntington's disease. Journal of The International Neuropsychological Society 2001;7:92-101. (Pubitemid 32177860)
20. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123:2091-2108.
21. Norton LE, Malloy PF, Salloway S. The impact of behavioral symptoms of activities of daily living in patients with dementia. American Journal of Geriatric Psychiatry 2001;9(1):41-48. (Pubitemid 32062071)
22. Rymer S, Salloway S, Norton L, Malloy P, Correia S, Monast D. Impaired awareness, behaviour disturbance, and caregiver burden in Alzheimer disease. Alzheimer Disease & Associated Disorders 2002;16(4):248-253. (Pubitemid 35434801)
23. Puente AE, Pérez-García M. Neuropsychological assessment of ethnic minorities: Clinical issues. In: Cuellar I, Paniagua FA, editors. Handbook of Multicultural Mental Health. San Diego, CA: Academic Press; 2000. pp 419-435.
24. Ministerio de Sanidad y Consumo. Plan Nacional sobre Drogas, Informe 2004. Retrieved March 12, 2007, from www.pnsd.msc.es/Categoria2/observa/oed/ home.htm 2004 http://www.pnsd.msc.es/Categoria2/observa/oed/home.htm 2004